Public Event Detail
28,037 Shares in CRISPR Therapeutics AG $CRSP Bought by Blue Jean Financial LLC
Public historical observation from the Merrowstone archive. This page shows event-level context only. Accepted assertions, evidence lineage, and relationship intelligence remain part of the premium research layer.
Event summary
Blue Jean Financial LLC initiated a new position in CRISPR Therapeutics AG (NASDAQ:CRSP) during the fourth quarter, purchasing 28,037 shares valued at approximately $1.47 million. Institutional investment in CRISPR Therapeutics remains robust, with hedge funds and other investors holding 69.20% of the company's stock, including significant increases from JPMorgan Chase & Co. and UBS Group AG. Despite reporting a quarterly loss of $1.28 per share and limited revenue, analysts maintain a "Moderate Buy" rating with an average price target of $67.78.